Updates in Hypertension Management: What to Expect from JNC VIII

This presentation was given at the conferenced entitled, "2009 Advances in Pharmacy Practice Annual Fall Conference" in Lexington, Kentucky on Ocotber 30 - November 1, 2009.

Faculty

Needs Statement

A recent study from the NIH indicates that there are 50 million or more Americans have high BP warranting some form of treatment. Periodically there are new guidelines released designed to increase awareness, prevention, treatment and control of hypertension. Educating providers on the new guidelines will hopefully increase patient care.

For more than three decades, the National Heart, Lung, and Blood Institute (NHLBI) has administered the National High Blood Pressure Education Program (NHBPEP) Coordinating Committee, a coalition of 39 major professional, public, and voluntary organizations and 7 Federal agencies. One important function is to issue guidelines and advisories designed to increase awareness, prevention, treatment, and control of hypertension (high blood pressure [BP]).

Data from the National Health and Nutrition Examination Survey (NHANES) have indicated that 50 million or more Americans have high BP warranting some form of treatment.1,2 Worldwide prevalence estimates for hypertension may be as much as 1 billion individuals, and approximately 7.1 million deaths per year may be attributable to hypertension.3 The World Health Organization reports that suboptimal BP (>115 mmHg SBP) is responsible for 62 percent of cerebrovascular disease and 49 percent of ischemic heart disease (IHD), with little variation by sex. In addition, suboptimal BP is the number one attributable risk factor for death throughout the world.3

NIH Publication No. 04-5230; August 2004; page 1: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Target Audience

Any healthcare provider interested in improving patient care.

Objectives

1. Review and assess major pharmacotherapeutic developments in hypertension since the release of the Joint National Committee (JNC VII) guidelines
2. Identify the major guideline recommendations likely to change based on new literature and insights from international hypertension organizations

Accreditation

CME
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

CPE
The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This knowledge-based activity has been assigned ACPE # 022-000-09-128-H01-P and will award 1.00 contact hour (0.1 CEU) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of credit will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. The College complies with the Accreditation Standards for Continuing Pharmacy Education.

Faculty Disclosure

Steven Dunn has nothing to disclose.